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ABSTRACT 
 
Background: Diabetes mellitus (type 2 DM) is now ranked first in health problems and its 
prevalence tends to increase worldwide. The Diabetes Control and Complication Trial (DCCT) 
study showed that lowering HbA1c rates may delay or prevent chronic complications. One of the 
risk factors for CHD in type 2 DM is dyslipidemia, i.e lipid metabolism disorders in the form of 
elevated total cholesterol, triglyceride (TG), low-density lipoprotein (LDL), and decreased levels of 
high-density lipoprotein (HDL). This study aimed to determine the correlation between HBA1C 
and blood sugar, as well as lipid profile in patients with type 2 DM. 
Subject and Methods: This was an analytic observational study with a cross-sectional design. 
The study was conducted at the Endocrinology and Metabolic polyclinic Pirngadi Hospital, Medan, 
North Sumatera, from January to February 2018. A total sample of 10 patients diagnosed as type 2 
diabetes mellitus with obesity was selected for this study. The independent variables were blood 
sugar, lipid profile including total cholesterol, high density lipoprotein (HDL), low density 
lipoprotein (LDL), and triglyceride. The dependent variable was HbA1c level. Lipid profile was 
measured by blood serum examination. HbA1c level was measured by blood serum examination. 
The data were analyzed by Pearson correlation. 
Results: Hba1c was positively correlated with blood sugar levels and was statistically significant 
(r= 0.81; p= 0.005). HbA1c correlated weakly and was statistically non-significant with total 
cholesterol (r= 0.14, p= 0.702), LDL (r= 0.15; p= 0.683), HDL (r= 0.04; p= 0.922), and 
triglycerides (r= 0.06; p= 0.860). 
Conclusion: HbA1c correlates with blood sugar levels but does not show correlation with lipid 
profiles. 
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BACKGROUND 
Diabetes Mellitus Type 2 (DMT2) is a 
heterogeneous metabolic disorder charac-
terized by hyperglycemia that occurs due to 
insulin secretion abnormalities, insulin 
work or both and both genetically and clini-
cally with symptoms of a lack of carbo-
hydrate tolerance. The World Health Orga-
nization (WHO) has previously formulated 
that DM is something that cannot be 
answered and discussed in a clear and 
concise manner but can generally be stated 
to be a collection of anatomical and chemi-
cal problems resulting from a number of 
factors in which there is an absolute or 
relative insulin deficiency and function im-
pairment insulin (Price, 2006, ADA, 2014). 
DM has now ranked first in health 
issues. The main findings of diabetes 
studies by the Diabetes Control and Com-
plication Trial (DCCT) have demonstrated 
the importance of HbA1c testing. Studies 
show that lowering HbA1c rates may delay 
or prevent chronic complications (Sultan-
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pur et al., 2010; Kumar and Singh, 2011; 
Loei et al., 2013). 
The prevalence of DMT2 disease 
increases along with the increase of BMI 
(body mass index) due to increased adipose 
tissue characterized by decreased HDL and 
increased triglycerides (Koampa, et al, 
2016). High BMI has a 2-fold greater risk of 
developing DMT2 compared to low BMI 
(Susilowati, 2015). 
HbA1c examination should be consi-
dered as monitoring for diabetes screening 
and diagnosis. The benefits of HbA1c are to 
assess the quality of index control or long-
term glycemic levels and assess the effectti-
veness of therapy, but recent studies sup-
port the wider use of HbA1c, not only for 
monitoring but also useful for diagnosing 
or screening for type 2 DM (Soulimane et 
al., 2011, PERKENI, 2015; Muraliswaran et 
al., 2016). 
One of the risk factors for CHD in 
type 2 diabetes is dyslipidemia, ie lipid 
metabolism disorders in the form of elevat-
ed total cholesterol, triglyceride (TG), low 
density lipoprotein (LDL), and decreased 
levels of high density lipoprotein (HDL). 
The description of dyslipidemia in type 2 
DM most frequently found is an increase in 
TG levels and the decreaseof HDL levels. 
Although LDL levels do not always in-
crease, LDL particles will undergo adjust-
ment of modifications into small and 
densely atherogenic forms (Adam, 2004; 
Karel, 2006; Hendromartono, 2006 and 
Noviyanti et al., 2011; Adam, 2014). 
HbA1c examination is used routinely 
for long-term glycemic control and can be 
used as a marker of lipid profile levels. 
Because of high HbA1c levels, LDL choles-
terol is also high, leading to an increased 
cardiovascular risk (Muraliswaran et al., 
2016). 
Based on previous studies, it was 
found that hyperglycemic conditions have 
direct and indirect effects. The indirect 
effects of hyperglycemic conditions are esti-
mated by their effect on lipid profiles. 
Considering this fact, a study entitled the 
correlation between HbA1c and lipid profile 
in patients with type 2 diabetes mellitus 
was conducted. 
 
SUBJECTS AND METHOD 
The study was conducted using obser-
vational analytic with cross sectional study 
approach. In this study, there was no 
follow-up action on the measurements 
done. It was conducted on a set of objects, 
in a certain period of time which aims to 
determine the relationship of HbA1c levels 
with lipid profile in patients with type 2 
diabetes. Ten obese patients with type 2 
diabetes who seek treatment at Endocrine 
and Metabolic PolyclinicsPirngadihospital 
Medan from January to February 2018 
were recruited as the samples. 
Inclusion Criteria 
a) Men/Women> 18 years old who suffer 
from type 2 DM. 
b) Patients are willing to give written 
permission after given informed consent 
to participate in this study. 
c) Patients who do not take anti-cholesterol 
drugs for 1 month 
d) Patients with BMI> 27 (obesity I and 
obesity II) 
Exclusion Criteria 
a) The patients are severely ill or are not 
allowed to participate in this research. 
b) The patients are not cooperative. 
c) Patients suffering from chronic diseases. 
The variables studied in this research are: 
1. The independent variable is HbA1c level 
2. The dependent variable is the lipid 
profile (Total Cholesterol, HDL, LDL and 
Triglycerides). 
In this study, patients’ lipid profile 
data obtained from the report of laboratory 
results attached and the way of measure-
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ment by looking at the data lipid profile of 
laboratory examination results are in units 
of mg / dl. HbA1c levels in type 2 diabetes 
mellitus are according to PERKENI 2015 
with unit percent (%). 
The data were analyzed using statis-
tical calculation to perform hypothesis test 
by Pearson correlation test method. If the 
normality test shows that the data are not 
normally distributed then the hypothesis 
test can be done using Spearman corre-
lation test method. 
 
RESULTS 
Of the 10 diabetes patients outpatient in the 
Internal Medicine Section at Endocrine and 
Metabolic Polyclinics hospital, there was 
characteristics found and presented in 
Table 1. 
Table 1.The Characteristics of Subjects 
Characteristics Mean ± SD 
Age (years)  57.9±11.98 
Weight (kg)* (Median,Min,Max)  73.5 (70.106) 
Height (cm)  
Cholesterol total 
HDL 
LDL 
Trigliserida 
HbA1c 
152.00±6.91 
220.4±46.21 
54.2±12.53 
130.3±32.22 
179.40±82.58 
9.8±2.45 
Sistole 
Diastole 
137±13.37 
86±9.66 
*not normally distributed 
Md: Median, Min: minimum, Max: maximum 
Based on the results of the correlative 
test, it was found a positive correlation 
between HbA1c with total cholesterol, HDL, 
LDL and blood triglycerides (r = 0.139; r = 
0.036; r= 0.148; r= 0.064) but it was not 
significant. This means that the worse 
HbA1c levels, the better the increase in lipid 
profile. This can be explained by the patho-
genesis of type 2 DM during the advanced 
phase in which in this phase, excess glucose 
in the blood is stored in the form of fat. 
From the data obtained, there was a 
significant correlation between HbA1c and 
the blood sugar level (p= 0.005). (Table 2). 
Table 2. The Correlation Between 
HbA1c and Lipid Profile 
Variable r p 
Total Cholesterol 0.139 0.702 
HDL 0.036 0.922 
LDL 0.148 0.683 
Triglycerides 0.064 0.680 
Glucose 0.808 0.005 
 
On Table 3,the average level of HbA1c 
from the pre-hypertension group was 11.06, 
stage 1 hypertension with HbA1c= 9.42 and 
stage 1 hypertension with HbA1c= 8.85. 
Table 3. The Average of HbA1c Level Based on Hypertension Descriptions 
Group 
Hba1c 
Mean±SD 
Pre-hypertension 11.06±1.5 
Stage 1 Hypertension 9.42±2.96 
Stage 2 Hypertension 8.85±2.6 
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DISCUSSIONS 
In this study, there were 10 samples who 
fulfilled the inclusion and exclusion crite-
ria. The sample consisted of 1 man (10%) 
and 9 women (90%).A study by Yang 
(2010) also showed similar result. It was 
stated that most DM patients were female. 
The average of HbA1c pateients was 
9.8%. The average of total cholesterol level 
was 220.4 gr/dl, the level of HDL was 54.2 
gr/dl, the level of LDL was 130.3 gr/dl, the 
average of triglycerides was 179.4 gr/dl and 
the average of HBA1c level was 9.8 % 
(Table 1). 
One-way correlative test was imple-
mented to determine the relationship bet-
ween HbA1c with lipid profile in patients 
with type 2 diabetes mellitus with obesity. 
The results of correlative analytic test 
between glycemic control, lipid profile can 
be seen in table 2. The results showed that 
there was a positive correlation between 
HbA1c and total cholesterol levels (r= 0.14; 
p= 0.702). This was similar to previous 
study done by Singh and Kumar (2011), this 
study showed that there was no significant 
relationship between HbA1clevel and total 
cholesterol level. However, there was a 
positive relationship between them. There 
was a positive correlation between LDL 
level (r= 0.148; p= 0.683), HDL level (r= 
0.036; p= 0.922) and Triglycerides level 
(r= 0.064; p= 0.860) but it was statistically 
non significant.  
In this study, there was a significant 
correlation of HbA1c with blood sugar level 
(p=0,005).This implied that poor control of 
glucose metabolism was characterized by 
elevated blood sugar levels/ hyperglycemia. 
Poor HbA1c levels reflecting poor patient 
adherence to diabetic therapy. Diabetic 
therapy is a therapy given to DM patients to 
assess the benefits of treatment and as a 
handbook of dietary adjustment, physical 
exercise, and medication to achieve normal 
blood glucose levels, and avoid hypergly-
cemia or hypoglycemia. The effectiveness of 
diabetic therapy depend on the results of 
HbA1c test (Kilpatrick, 2008; Charitha, 
2013; Lindarto, 2014). 
According to Soesilowati (2012), 
stated that in normal people, a small frac-
tion of hemoglobin would experience gly-
cosylation. This mean that glucose was 
bound to hemoglobin through non-enzym-
atic processes and it was reversible. In DM 
patients, glycosylation of hemoglobin in-
creased proportionately with blood glucose 
levels during the previous 2-3 months. If 
the blood glucose level was in the normal 
range between 70 -140 mg% for the last 2 -
3 months, then HbA1c test result would 
show a normal score. Due to slow replace-
ment of hemoglobin, high HbA1c scores 
suggest that blood glucose levels were 
enhance for 4-8 weeks (Schteingart and 
David, 2013; Singh at al., 2014). 
In the previous study according to the 
European Association for the Study of 
Diabetes (EASD) and International Dia-
betes Federation (IDF) in Paputungan and 
Sanusi (2014); which involved 600 parti-
cipants in 11 countries through 24-hour 
glucose monitoring and HbA1c measure-
ments showed a close relationship between 
blood glucose and HbA1c.  
HbA1c was currently used as a glyce-
mic indicator because it reflected glucose 
concentration in 1-2 months before test and 
was not influenced by diet before blood 
sampling. HBA1c was a monitoring tool in 
the management of patients with DM 
(Stopler and William, 2016). 
This study also showed that the lower 
the HbA1c level, the lower the blood 
pressure. This determination can be caused 
by differences in standardization of hyper-
tension control used. Because this research 
was a cross sectional study, the relationship 
obtained was only an estimate of relative 
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risk. The causal relationships between va-
riables still cannot be determined. Because 
the data collection was done without paying 
attention to the variables that appear first. 
The weakness in this study was a 
cross sectional study with limitations: 1. 
Not all confounding variables can be well 
controlled, therefore, further research was 
needed with appropriate research design. 2. 
This study was based on local state 
hospitals, therefore, to globally generalize a 
diabetes mellitus type 2 population with 
obesity should be wiser. 3. The number of 
samples was limited, therefore, more 
samples are needed. 
It suggested further study with more 
varied samples is needed in order to prove 
the association between HbA1c and lipid 
profiles in patients with type 2 diabetes 
with obesity. 
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